Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Qubic Hits Self Reported Market Cap of $479.47 Million (QUBIC)
Qubic (QUBIC) traded down 2.6% against the US dollar during the 1 day period ending at 8:00 AM E.T. on...
PARSIQ Achieves Market Capitalization of $44.89 Million (PRQ)
PARSIQ (PRQ) traded up 23.8% against the dollar during the twenty-four hour period ending at 8:00 AM Eastern on December...
OpenBlox Trading 17.6% Higher Over Last Week (OBX)
OpenBlox (OBX) traded up 0.6% against the dollar during the 24 hour period ending at 8:00 AM E.T. on December...
Head-To-Head Contrast: TruGolf (TRUG) vs. The Competition
Institutional and Insider Ownership 3.2% of TruGolf shares are held by institutional investors. Comparatively, 49.9% of shares of all “Sporting...
Northeast Financial Consultants Inc Decreases Stock Holdings in iShares U.S. Medical Devices ETF (NYSEARCA:IHI)
Northeast Financial Consultants Inc lowered its stake in iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report) by 6.4% during...
Northeast Financial Consultants Inc Has $10.25 Million Holdings in Mplx Lp (NYSE:MPLX)
Northeast Financial Consultants Inc lifted its position in Mplx Lp (NYSE:MPLX – Free Report) by 0.4% in the third quarter,...